Aveanna Healthcare (AVAH) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40%. A quarter ago, it was expected that this home health care services provider would post a loss of $0.02 per share when it actually produced a loss of $0.01, delivering a surprise of 50%.Over the last four quarters, ...

First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period Adjusted EBITDA was $34.9 million, a 22.5% increase as compared to the prior year quarter Full Year 2024 Revenue guidance raised to greater than $1,970 million Full Year 2024 Adjusted EBITDA guidance raised to greater than $150 million ATLANTA, May ...

Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year o Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 • First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period o Adjusted EBITDA was $34.9 million, a 22.5% increase as compared to the prior year quarter • Full Year 2024 Revenue guidance raised ...

The upcoming report from Aveanna Healthcare (AVAH) is expected to reveal quarterly loss of $0.05 per share, indicating no change from the year-ago quarter compared to the year-ago period. Analysts forecast revenues of $485.05 million, representing an increase of 4% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company ...

ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Barclays Leveraged Finance Conference in Austin, TX on May 21, 2024. Management will host 1x1 investor meetings that day. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 33 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupatio ...

ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC Capital Markets Global Healthcare Conference in New York on May 14, 2024. Management will host 1x1 investor meetings as well as a fireside chat at 10:30 a.m. Eastern Time on the same day, May 14, 2024. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging onto the Investor Relations section ...

ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) --  Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by di ...

ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare indus ...

Financial Data and Key Metrics - Q4 2023 revenue was $479 million, a 6.1% increase YoY [5] - Q4 2023 adjusted EBITDA was $38.7 million, a 30.4% increase YoY, driven by improved payor rates and cost reduction efforts [5] - Full-year 2023 revenue was $1.895 billion, a 6% increase YoY, and adjusted EBITDA was $139.2 million, a 7.6% increase YoY [6] - Full-year 2024 revenue is expected to be between $1.96 billion and $1.98 billion, with adjusted EBITDA between $146 million and $150 million [14][24] Business Line Performance Private Duty Services (PDS) - Q4 2023 PDS revenue was $383 million, a 6.1% increase YoY, driven by 10.1 million hours of care, a 5.1% volume increase YoY [17] - Revenue per hour for PDS was $38.04, up 1% YoY [17] - Gross margin for PDS was 27%, a 12.7% increase YoY, with a cost of revenue rate of $27.76, flat sequentially [18] - The company achieved double-digit PDS rate increases in eight key states, with 19 states representing 55% of PDS footprint [8] Home Health & Hospice - Q4 2023 revenue was $54 million, a 1.1% decrease YoY, with 9,200 total admissions and 11,300 episodes of care [18] - Medicare revenue per episode was $3,064, up 1.8% YoY [18] - Gross margin for Home Health & Hospice was 50.9%, reflecting cost initiatives and a focus on episodic payors [19] - The episodic mix improved from 60% in 2022 to 74% in Q4 2023 [11] Medical Solutions - Q4 2023 revenue was $41.3 million, a 17.5% increase YoY, driven by 90,000 unique patients served, an 8.4% increase YoY [20] - Revenue per unique patient served (UPS) was $458.80 [20] - Gross margin for Medical Solutions was 42%, up 2.3% YoY [21] Market and Strategic Focus - The company is focusing on enhancing partnerships with government and preferred payors to create caregiver capacity [13] - The labor market remains a challenge, but the company is seeing improvements in caregiver hiring and retention trends [7] - The company is targeting a 70% preferred payor penetration in Texas PDN volumes by 2024 [11] - In California, the company is accelerating its preferred payor strategy while continuing legislative efforts for rate increases [35] Management Commentary on Operating Environment and Future Outlook - The company expects 20% of full-year 2024 adjusted EBITDA to be recognized in Q1 and 44% in the first half of 2024 [24] - The company is optimistic about continued rate improvements and volume growth in 2024 [22] - The company aims to return to a 10% adjusted EBITDA margin in the long term [29] Other Important Information - The company ended Q4 2023 with $232 million in liquidity, including $43.9 million in cash and $168 million available under its revolver [22] - Cash provided by operating activities was $22.7 million in Q4, with free cash flow of $12.5 million [24] - The company has no material term loan maturities until July 2028 [23] Q&A Session Summary Question 1: Margin Expectations for 2024 - The company expects gross margins to remain consistent with Q3 and Q4 2023 levels, with potential outperformance from preferred payor agreements and state rate increases [30][32] - The company is focused on reinvesting rate increases into caregiver wages to drive volume growth [30] Question 2: Labor Environment and Wage Inflation - The company plans to pass through rate increases to caregivers to improve hiring and retention [32] - Wage inflation is expected to be managed through rate improvements and cost efficiencies [32] Question 3: Preferred Payor Progress in California - The company is accelerating its preferred payor strategy in California, with a focus on both legislative efforts and commercial plans [35] - The company has two preferred payors in California, paying above the Medicaid PDN rate [35] Question 4: Upside Potential Across Business Lines - The Home Health & Hospice business has shown significant improvement, with a focus on episodic payors and improved clinical outcomes [38] - The company expects continued growth in PDS and Medical Solutions, driven by rate increases and volume growth [38] Question 5: Cash Flow and Working Capital Dynamics - The company expects moderate headwinds in Q1 2024 due to seasonality but anticipates positive operating cash flow for the year [40] - The company is considering small M&A opportunities in the back half of 2024 or 2025 [40] Question 6: Margin Expansion and Revenue Growth - Margin expansion in 2024 is expected to come primarily from SG&A efficiencies, with minimal improvement in gross margins [45] - Revenue growth in PDS is expected to be split evenly between rate and volume increases [48]

Aveanna Healthcare (AVAH) reported $478.84 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 6.1%. EPS of -$0.01 for the same period compares to -$0.03 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $464.33 million, representing a surprise of +3.12%. The company delivered an EPS surprise of +50.00%, with the consensus EPS estimate being -$0.02.While investors closely watch year-over-year changes in headline numbers -- revenue and e ...